FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2412282719> ?p ?o ?g. }

• W2412282719 abstract "To explore the relationship between anti-interferon-alpha (anti-IFN- alpha) antibodies and loss of clinical responsiveness to IFN-alpha treatment, we examined sera from 59 patients with hairy cell leukemia who responded to therapy with recombinant IFN-alpha-2a (rIFN-alpha-2a). During the first 2 years of therapy, 10 patients developed rIFN-alpha- 2a-neutralizing and 15 rIFN-alpha-2a-binding antibodies. Nine of the 59 initially responding patients became resistant to rIFN-alpha-2a and suffered a relapse of the disease at 7 to 24 months of treatment. All nine relapsing patients tested positive for both neutralizing and binding antibodies with titers above 400 INU/mL, while none of the antibody-negative patients relapsed. Six patients with detectable binding antibody titers below 400 INU/mL continued to respond to treatment. By measuring the IFN kinetics and the levels of the IFN- induced Mx-homologous protein in mononuclear cells after a single injection each of rIFN-alpha-2a and nIFN-alpha the IFN antibodies of eight of the nine resistant rIFN-alpha patients were found to be highly specific for rIFN-alpha-2a. Therefore, these eight patients were switched to natural IFN-alpha (nIFN-alpha) therapy at doses of 3 million IU, three times a week. All eight patients responded to treatment with nIFN-alpha, achieving durable objective responses similar to those obtained previously with rIFN-alpha-2a. These data clearly demonstrate that rIFN-alpha antibody-positive patients can effectively be treated with nIFN-alpha." @default.
• W2412282719 created "2016-06-24" @default.
• W2412282719 creator A5011557387 @default.
• W2412282719 creator A5015932441 @default.
• W2412282719 creator A5029562517 @default.
• W2412282719 creator A5035707250 @default.
• W2412282719 creator A5039271028 @default.
• W2412282719 creator A5043414993 @default.
• W2412282719 creator A5046120401 @default.
• W2412282719 creator A5056609078 @default.
• W2412282719 creator A5069067644 @default.
• W2412282719 creator A5070685325 @default.
• W2412282719 date "1991-07-01" @default.
• W2412282719 modified "2023-10-01" @default.
• W2412282719 title "Effective natural interferon-alpha therapy in recombinant interferon- alpha-resistant patients with hairy cell leukemia" @default.
• W2412282719 cites W1643040145 @default.
• W2412282719 cites W1875354643 @default.
• W2412282719 cites W1935526529 @default.
• W2412282719 cites W1977983409 @default.
• W2412282719 cites W1978242550 @default.
• W2412282719 cites W1991652975 @default.
• W2412282719 cites W1995628336 @default.
• W2412282719 cites W1995631340 @default.
• W2412282719 cites W2005552514 @default.
• W2412282719 cites W2006839937 @default.
• W2412282719 cites W2007712275 @default.
• W2412282719 cites W2050600382 @default.
• W2412282719 cites W2055231645 @default.
• W2412282719 cites W2076427033 @default.
• W2412282719 cites W2091703047 @default.
• W2412282719 cites W2097160811 @default.
• W2412282719 cites W2124918726 @default.
• W2412282719 cites W2167970439 @default.
• W2412282719 cites W2194357108 @default.
• W2412282719 cites W2412373333 @default.
• W2412282719 cites W2414215486 @default.
• W2412282719 cites W2415938066 @default.
• W2412282719 cites W2462276446 @default.
• W2412282719 doi "https://doi.org/10.1182/blood.v78.1.38.bloodjournal78138" @default.
• W2412282719 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2070058" @default.
• W2412282719 hasPublicationYear "1991" @default.
• W2412282719 type Work @default.
• W2412282719 sameAs 2412282719 @default.
• W2412282719 citedByCount "22" @default.
• W2412282719 crossrefType "journal-article" @default.
• W2412282719 hasAuthorship W2412282719A5011557387 @default.
• W2412282719 hasAuthorship W2412282719A5015932441 @default.
• W2412282719 hasAuthorship W2412282719A5029562517 @default.
• W2412282719 hasAuthorship W2412282719A5035707250 @default.
• W2412282719 hasAuthorship W2412282719A5039271028 @default.
• W2412282719 hasAuthorship W2412282719A5043414993 @default.
• W2412282719 hasAuthorship W2412282719A5046120401 @default.
• W2412282719 hasAuthorship W2412282719A5056609078 @default.
• W2412282719 hasAuthorship W2412282719A5069067644 @default.
• W2412282719 hasAuthorship W2412282719A5070685325 @default.
• W2412282719 hasBestOaLocation W24122827191 @default.
• W2412282719 hasConcept C104317684 @default.
• W2412282719 hasConcept C126322002 @default.
• W2412282719 hasConcept C141071460 @default.
• W2412282719 hasConcept C159047783 @default.
• W2412282719 hasConcept C159654299 @default.
• W2412282719 hasConcept C203014093 @default.
• W2412282719 hasConcept C2775944032 @default.
• W2412282719 hasConcept C2776178377 @default.
• W2412282719 hasConcept C2778690821 @default.
• W2412282719 hasConcept C2780841837 @default.
• W2412282719 hasConcept C2781228144 @default.
• W2412282719 hasConcept C2909179924 @default.
• W2412282719 hasConcept C32611913 @default.
• W2412282719 hasConcept C40767141 @default.
• W2412282719 hasConcept C49453240 @default.
• W2412282719 hasConcept C55493867 @default.
• W2412282719 hasConcept C64943373 @default.
• W2412282719 hasConcept C71924100 @default.
• W2412282719 hasConcept C86803240 @default.
• W2412282719 hasConceptScore W2412282719C104317684 @default.
• W2412282719 hasConceptScore W2412282719C126322002 @default.
• W2412282719 hasConceptScore W2412282719C141071460 @default.
• W2412282719 hasConceptScore W2412282719C159047783 @default.
• W2412282719 hasConceptScore W2412282719C159654299 @default.
• W2412282719 hasConceptScore W2412282719C203014093 @default.
• W2412282719 hasConceptScore W2412282719C2775944032 @default.
• W2412282719 hasConceptScore W2412282719C2776178377 @default.
• W2412282719 hasConceptScore W2412282719C2778690821 @default.
• W2412282719 hasConceptScore W2412282719C2780841837 @default.
• W2412282719 hasConceptScore W2412282719C2781228144 @default.
• W2412282719 hasConceptScore W2412282719C2909179924 @default.
• W2412282719 hasConceptScore W2412282719C32611913 @default.
• W2412282719 hasConceptScore W2412282719C40767141 @default.
• W2412282719 hasConceptScore W2412282719C49453240 @default.
• W2412282719 hasConceptScore W2412282719C55493867 @default.
• W2412282719 hasConceptScore W2412282719C64943373 @default.
• W2412282719 hasConceptScore W2412282719C71924100 @default.
• W2412282719 hasConceptScore W2412282719C86803240 @default.
• W2412282719 hasLocation W24122827191 @default.
• W2412282719 hasOpenAccess W2412282719 @default.
• W2412282719 hasPrimaryLocation W24122827191 @default.
• W2412282719 hasRelatedWork W1875354643 @default.
• W2412282719 hasRelatedWork W1973385519 @default.
• W2412282719 hasRelatedWork W1977983409 @default.

• next